scholarly article | Q13442814 |
P50 | author | Gianpiero L. Cavalleri | Q46969101 |
P2093 | author name string | D. B. Goldstein | |
M. Angrist | |||
Y.-F. Lu | |||
P2860 | cites work | An evolutionary approach to the high frequency of the Delta F508 CFTR mutation in European populations. | Q47411485 |
Gene Differences between Caucasian, Negro, and Japanese Populations | Q70417098 | ||
Finding the missing heritability of complex diseases | Q22122198 | ||
A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases | Q24534086 | ||
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population | Q24606497 | ||
A map of human genome variation from population-scale sequencing | Q24617794 | ||
De novo mutations in epileptic encephalopathies | Q24621776 | ||
The population genetics of the Jewish people | Q24633199 | ||
Evaluating candidate agents of selective pressure for cystic fibrosis | Q24654240 | ||
Global epidemiology of hepatitis C virus infection | Q27860799 | ||
Cystic fibrosis | Q28212180 | ||
Protective effects of the sickle cell gene against malaria morbidity and mortality | Q28215309 | ||
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 | ||
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
The 1000 Genomes Project: new opportunities for research and social challenges | Q33693714 | ||
Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review | Q33900242 | ||
The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
Tay-Sachs disease | Q34347943 | ||
Genetic and geographical variability in cystic fibrosis: evolutionary considerations. | Q34399381 | ||
Natural history of Ashkenazi intelligence | Q34551013 | ||
Next generation disparities in human genomics: concerns and remedies | Q35008340 | ||
Clinical implications of human population differences in genome-wide rates of functional genotypes | Q36361047 | ||
Genomics for the world | Q37003231 | ||
Uncovering the roles of rare variants in common disease through whole-genome sequencing | Q37755970 | ||
Recent developments in the genetics of autism spectrum disorders | Q38093928 | ||
Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. | Q42981999 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | genetic diversity | Q585259 |
personalized medicine | Q2072214 | ||
P304 | page(s) | a008581 | |
P577 | publication date | 2014-07-24 | |
P1433 | published in | Cold Spring Harbor Perspectives in Medicine | Q21042440 |
P1476 | title | Personalized medicine and human genetic diversity | |
P478 | volume | 4 |
Q92898086 | A Clinician's Perspective on Biomarkers |
Q93086744 | A core collection of pan-schizophrenia genes allows building cohort-specific signatures of affected brain |
Q38593055 | A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. |
Q49385295 | Activation of Nrf2 signaling by natural products-can it alleviate diabetes? |
Q38656488 | An Integrative Computational Approach to Evaluate Genetic Markers for Bipolar Disorder. |
Q64235258 | Analysis of Benefit of Intensive Care Unit Transfer for Deteriorating Ward Patients: A Patient-Centered Approach to Clinical Evaluation |
Q91866776 | Artificial intelligence-assisted prediction of preeclampsia: Development and external validation of a nationwide health insurance dataset of the BPJS Kesehatan in Indonesia |
Q90164481 | Can education be personalised using pupils' genetic data? |
Q50060353 | Dielectrophoretic analysis of treated cancer cells for rapid assessment of treatment efficacy |
Q38665568 | Evaluation of Quality Assessment Protocols for High Throughput Genome Resequencing Data |
Q50123812 | Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine. |
Q31154892 | Genomics pipelines and data integration: challenges and opportunities in the research setting. |
Q95642983 | Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple Cohorts |
Q26749581 | How to Predict Molecular Interactions between Species? |
Q39788339 | INPS-MD: a web server to predict stability of protein variants from sequence and structure |
Q48071853 | Imaging biobanks in oncology: European perspective |
Q38651944 | Implications of human genetic variation in CRISPR-based therapeutic genome editing |
Q28829827 | Influence of chelator and near-infrared dye labeling on biocharacteristics of dual-labeled trastuzumab-based imaging agents |
Q92481647 | Innovation in Oncology Drug Development |
Q64230189 | Integrated Microfluidic Devices Fabricated in Poly (Methyl Methacrylate) (PMMA) for On-site Therapeutic Drug Monitoring of Aminoglycosides in Whole Blood |
Q30389939 | Large scale analysis of protein stability in OMIM disease related human protein variants |
Q38817013 | Linking neuroimaging signals to behavioral responses in single cases: Challenges and opportunities. |
Q47215897 | MPLasso: Inferring microbial association networks using prior microbial knowledge |
Q47870167 | Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges |
Q48139814 | Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs). |
Q41145493 | Neanderthal and Denisova tooth protein variants in present-day humans |
Q92956020 | Patient similarity by joint matrix trifactorization to identify subgroups in acute myeloid leukemia |
Q38578746 | Perspectives on Human Variation through the Lens of Diversity and Race |
Q26765823 | Population Genomics and the Statistical Values of Race: An Interdisciplinary Perspective on the Biological Classification of Human Populations and Implications for Clinical Genetic Epidemiological Research |
Q89519652 | Precise hepatectomy in the intelligent digital era |
Q42315922 | Precision Medicine in Cats: Novel Niemann-Pick Type C1 Diagnosed by Whole-Genome Sequencing |
Q57683879 | Precision Medicine: An Introduction |
Q59810611 | Prevention genetics program is an efficient model for precision medicine |
Q39287356 | Prostate cancer molecular profiling: the Achilles heel for the implementation of precision medicine |
Q39222032 | RNA Bioinformatics for Precision Medicine |
Q33870511 | Self-reported race and ethnicity of US biobank participants compared to the US Census |
Q37250779 | Serum γ-Glutamyltransferase, Alanine Aminotransferase and Aspartate Aminotransferase Activity in Healthy Blood Donor of Different Ethnic Groups in Gorgan |
Q28073967 | Toward precision medicine of breast cancer |
Q28067740 | Understanding rare and common diseases in the context of human evolution |
Q26750460 | Use of systems biology to decipher host-pathogen interaction networks and predict biomarkers |